Comparison of the host immune response to herpes simplex virus 1 (HSV-1) and HSV-2 at two different mucosal sites

Journal of Virology

Volumn 86, Issue 13, 2012, Pages 7454-7458

  Zheng, Min ^a   Conrady, Christopher D ^a   Ward, Julie M ^a   Bryant Hudson, Katie M ^a   Carr, Daniel J J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EYE INFECTION; EYE INFLAMMATION; FEMALE; GENITAL TRACT INFECTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IMMUNE RESPONSE; INFECTION RESISTANCE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VIRUS CONCENTRATION; VIRUS REPLICATION;

ANIMALS; CYTOKINES; FEMALE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; IMMUNITY, MUCOSAL; MICE; MICE, INBRED C57BL; VIRAL LOAD;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; MUS;

EID: 84864122223     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00702-12     Document Type: Article

References (41)

1. Ashkar AA, Rosenthal KL. 2003. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77:10168-10171.
2. Belshe RB, et al. 2012. Efficacy results of a trial of a herpes simplex vaccine. N. Engl. J. Med. 366:34-43.
3. Bertke AS, et al. 2011. A5-positive primary sensory neurons are nonpermissive for productive infection with herpes simplex virus 1 in vitro. J. Virol. 85:6669-6677.
4. Bhattarakosol P, Visaprom S, Sangdara A, Mungmee V. 2005. Increase of genital HSV-1 and mixed HSV-1 and HSV-2 infection in Bangkok, Thailand. J. Med. Assoc. Thai. 88(SUPPL. 4):S300-S304.
5. Immunization with a dominant-negative recombinant herpes simplex virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs
6. Carr DJJ, Wuest T, Ash J. 2008. An increase in herpes simplex virus type 1 in the anterior segment of the eye is linked to a deficiency in NK cell infiltration in mice deficient in CXCR3. J. Interferon Cytokine Res. 28: 245-251.
7. Chan T, Barra NG, Lee AJ, Ashkar AA. 2011. Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa. J. Reprod. Immunol. 88:210-218.
8. Dodd J, Jessell TM. 1985. Lactoseries carbohydrates specify subsets of dorsal root ganglion neurons projecting to the superficial dorsal horn of rat spinal cord. J. Neurosci. 5:3278-3294.
9. Gilbert M, et al. 2011. Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes. Can. J. Public Health 102:225-229.
10. Halford WP, Gebhardt BM, Carr DJJ. 1996. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type. J. Immunol. 157:3542-3549.
11. - virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine. PLoS One doi:10.1371/journal.pone.0017748. 6:e17748.
12. + T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J. Gen. Virol. 82:845-853.
13. Härle P, Noisakran S, Carr DJJ. 2001. The application of a plasmid DNA encoding IFN-α1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice. J. Immunol. 166:1803-1812.
14. Henken DB, Martin JR. 1992. The proportion of galanin-immunoreactive neurons in mouse trigeminal ganglia is transiently increased following corneal inoculation of herpes simplex virus type-1. Neurosci. Lett. 140:177-180.
15. Hu K, et al. 2011. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice. Vaccine 29:1455-1462.
16. Kaneko H, et al. 2008. Evaluation of mixed infection cases with both herpes simplex virus types 1 and 2. J. Med. Virol. 80:883-887.
17. Kim T, et al. 2010. Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 107:15181-15186.
18. Kortekangas-Savolainen O, Vuorinen T. 2007. Trends in herpes simplex virus type 1 and 2 infections among patients diagnosed with genital herpes in a Finnish sexually transmitted disease clinic, 1994-2002. Sex. Transm. Dis. 34:37-40.
19. Lewandowski G, Hobbs MV, Bloom FE. 1994. Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2. J. Neuroimmunol. 55:23-34.
20. Lindqvist M, Persson J, Thorn K, Harandi AM. 2009. The mucosal adjuvant effect of α-galactosylceramide for induction of protective immunity to sexually transmitted viral infection. J. Immunol. 182:6435-6443.
21. Looker KJ, Garnett GP, Schmid GP. 2008. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull. World Health Organ. 86:805-812.
22. Lu Z, et al. 2009. High-level expression of glycoprotein D by a dominantnegative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection. J. Invest. Dermatol. 129:1174-1184.
23. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. 2003. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513-520.
24. Milligan GN. 1999. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2. J. Virol. 73:6380-6386.
25. Milligan GN, Bernstein DI. 1997. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229:259-268.
26. Morello CS, Levinson MS, Kraynyak KA, Spector DH. 2011. Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease. J. Virol. 85:3461-3472.
27. Paludan SR, Bowie AG, Horan KA, Fitzgerald KA. 2011. Recognition of herpesviruses by the innate immune system. Nat. Rev. Immunol. 11:143-154.
28. Parr MB, Parr EL. 1998. Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J. Virol. 72:2677-2685.
29. Peña KC, Adelson ME, Mordechai E, Blaho JA. 2010. Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States. J. Clin. Microbiol. 48: 150-153.
30. Raftery MJ, et al. 1999. Herpes simplex virus type-1 infection of activated cytotoxic T cells: induction of fratricide as a mechanism of viral immune evasion. J. Exp. Med. 190:1103-1113.
31. Smith TJ, Ackland-Berglund CE, Leib DA. 2000. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice. J. Virol. 74:3598-3604.
32. Stanberry LR, et al. 2002. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 347:1652-1661.
33. Straus SE, et al. 1993. Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine. J. Infect. Dis. 167:1045-1052.
34. Taxini CL, Takakura AC, Gargaglioni LH, Moreira TS. 2011. Control of the central chemoreflex by A5 noradrenergic neurons in rats. Neuroscience 199:177-186.
35. Templeton A, Nguyen G, Ash JD, Straub RH, Carr DJJ. 2008. Chemical sympathectomy increases susceptibility to ocular herpes simplex virus type 1 infection. J. Neuroimmunol. 197:37-46.
36. Thapa M, Kuziel WA, Carr DJJ. 2007. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J. Virol. 81:3704-3713.
37. Unterholzner L, et al. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11:997-1004.
38. Whitley RJ, Roizman B. 2009. Herpes simplex viruses, Clinical virology, Richman DD, Whitley RJ, Hayden FG (ed), 3rd ed. ASM Press, Washington, DC. 409-449.
39. Wuest TR, Carr DJJ. 2008. Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection. J. Immunol. 181:7985-7993.
40. Wuest TR, Carr DJJ. 2010. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J. Exp. Med. 207:101-115.
41. + T cells and protects against herpes simplex virus type 2 challenge. Mucosal Immunol. 2:129-143.